China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced that it has received a 510(k) license from the US FDA for its Vericor, a peripheral support catheter designed to improve peripheral vascular pathways. This approval marks a significant milestone for Acotec in expanding its presence in the US medical device market.
Vericor Catheter Profile
Vericor is a peripheral support catheter used in conjunction with a guide wire to help recanalize chronic total occlusions (CTOs), including lesions above the knee (ATK) and below the knee (BTK). The device is designed to reduce the surgical difficulty associated with complex lesions and BTK lesions, offering a valuable tool for improving patient outcomes in peripheral vascular interventions.-Fineline Info & Tech
